SuppreMol GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:SuppreMol GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013265
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SuppreMol GmbH (SuppreMol), a subsidiary of Baxalta Inc, is a biopharmaceutical company that develops therapeutics in the areas of autoimmune, chronic inflammatory diseases, and allergies. The company’s lead drug candidate is extensively profiled in in-vitro, ex-vivo and in-vivo experiments. Its antibody is used to restrict cellular activation signals mediated by the B cell receptor. SuppreMol also works on anti-Fc?RIIb antibodies, which can be useful for the treatment of autoimmune diseases(and allergic reactions . The company conducts research and development to develop new drugs. SuppreMol is headquartered in Munich, Germany.

SuppreMol GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SuppreMol GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Suppremol Raises US$20.6 Million In Series D Financing 10
Licensing Agreements 11
SuppreMol Exercises Option For Licensing Agreement With Bayerische For RA Antibody 11
Acquisition 13
Baxter International Acquires SuppreMol for USD225 Million 13
SuppreMol GmbH – Key Competitors 14
SuppreMol GmbH – Key Employees 15
SuppreMol GmbH – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
SuppreMol GmbH, Pharmaceuticals & Healthcare, Key Facts 2
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SuppreMol GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SuppreMol GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Suppremol Raises US$20.6 Million In Series D Financing 10
SuppreMol Exercises Option For Licensing Agreement With Bayerische For RA Antibody 11
Baxter International Acquires SuppreMol for USD225 Million 13
SuppreMol GmbH, Key Competitors 14
SuppreMol GmbH, Key Employees 15

★海外企業調査レポート[SuppreMol GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Neusoft Medical Systems Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Neusoft Medical Systems Co Ltd (Neusoft Medical), a subsidiary of Neusoft Corp is a medical device company that provides medical equipment and services. The company offers medical imaging equipment, e-hospital solutions, regional medical and personal healthcare products. Its product portfoli …
  • Sumitomo Mitsui Construction Co Ltd (1821):企業の財務・戦略的SWOT分析
    Sumitomo Mitsui Construction Co Ltd (1821) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Team Health Holdings Inc-製薬・医療分野:企業M&A・提携分析
    Summary Team Health Holdings Inc (TeamHealth) is a healthcare organization that offers patient care services. The organization’s practice areas include emergency medicine, anesthesiology, hospital medicine, hospital medicine subspecialties, ambulatory care, post-acute care and behavioral health serv …
  • Promimic AB-医療機器分野:企業M&A・提携分析
    Summary Promimic AB (Promimic) is a biomaterial company that develops and markets implant surface modifications and synthetic bones. The company’s products comprise metals, ceramics, polymers, porous materials and pyrocarbon. Its HA-nano surface is a coating based on nanocrystalline hydroxyapatite p …
  • Nihon Medi-Physics Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Nihon Medi-Physics Co Ltd (NMCL), a subsidiary of Sumitomo Chemical Co Ltd, is a radioactive pharmaceuticals and radioactive medical device manufacturer. The company offers research, development, production, sale, purchase and import and export of radioactive pharmaceuticals, medical devices …
  • OpGen Inc (OPGN):企業の財務・戦略的SWOT分析
    OpGen Inc (OPGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Novant Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Novant Health Inc (Novant Health) is a not-for-profit, integrated healthcare service provider. The organization provides services related to assisted living, blood services, breast health, children’s services, laboratory services, emergency, laboratory services, cancer, urgent care, hospice …
  • Chesapeake Energy Corp (CHK):石油・ガス:M&Aディール及び事業提携情報
    Summary Chesapeake Energy Corp (Chesapeake) is an upstream oil and gas company in the US. The company explores for, develops and produces oil and gas from its assets. It has liquid operations in Eagle Ford Shale; the Utica Shale; the Granite Wash, Cleveland, Tonkawa and Mississippian Lime plays in t …
  • China Resources Power Holdings Co Ltd (836):企業の財務・戦略的SWOT分析
    China Resources Power Holdings Co Ltd (836) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Salesforce.Com Inc (CRM):企業の財務・戦略的SWOT分析
    Salesforce.Com Inc (CRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CRA International Inc (CRAI):企業の財務・戦略的SWOT分析
    Summary CRA International Inc (CRA) is a consulting firm that offers economic, financial, and strategic expertise to law firms, corporations, accounting firms and governments. The firm provides services such as accounting and forensic services, antitrust and competition, auctions and competitive bid …
  • Lincoln Electric System:企業の戦略的SWOT分析
    Lincoln Electric System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • PT. Indonesia Power:企業の発電所・SWOT分析2018
    PT. Indonesia Power - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • SciClone Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SciClone Pharmaceuticals Inc (SciClone), a subsidiary of Silver Biotech Investment Ltd, develops and commercializes products for the treatment of cancer, cardiovascular disorders and infectious diseases. The company’s lead product, Zadaxin (thymalfasin) is an immunostimulatory agent indicate …
  • Altria Group Inc (MO):企業の財務・戦略的SWOT分析
    Altria Group Inc (MO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Control4 Corporation (CTRL)-エネルギー分野:企業M&A・提携分析
    Summary Control4 Corporation (Control4) is a provider of automation systems and control solutions for homes and businesses. It focuses on smart lighting, networking solutions and safety and security solutions. The company offers personalized control solutions for lighting, video, music, energy and s …
  • MIS Implants Technologies Ltd-医療機器分野:企業M&A・提携分析
    Summary MIS Implants Technologies Ltd (MIS) is a medical device company that offers advanced products and solutions for dental implantology treatment. The company offers dental implants, tools and kits, superstructures, and solutions for oral restoration and health, among others. Its implants compri …
  • AMAG Austria Metall AG:企業の戦略・SWOT・財務情報
    AMAG Austria Metall AG - Strategy, SWOT and Corporate Finance Report Summary AMAG Austria Metall AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PixarBio Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary PixarBio Corp (PixarBio), formerly BMP Holdings Inc is a biotechnology company that discovers and develops novel neurological drug delivery systems for postsurgical pain, acute pain, and chronic pain. The company offers research and commercial development of targeted drug delivery systems, b …
  • Kuraray Co Ltd (3405):企業の財務・戦略的SWOT分析
    Kuraray Co Ltd (3405) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆